The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: A randomized clinical trial

Age

Volumn 32, Issue 2, 2010, Pages 179-186

  Sharif, Pooneh Salari ^a   Asalforoush, Mahsa ^b   Ameri, Fatemeh ^b   Larijani, Bagher ^c   Abdollahi, Mohammad ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone alkaline phosphatase; n 3 fatty acids; Osteocalcin; Osteoporosis; Pyridinoline

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; OMEGA 3 FATTY ACID; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBO; PYRIDINOLINE; VITAMIN D;

ADULT; ARTICLE; ASIAN; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; FEMALE; HUMAN; IRAN; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; URINE LEVEL; VITAMIN BLOOD LEVEL;

BIOLOGICAL MARKERS; BONE DENSITY; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; IRAN; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 77953023230     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-009-9122-3     Document Type: Article

References (26)

1. Abdollahi M, Larijani B, Rahimi R, Salari P (2005) Role of oxidative stress in osteoporosis. Therapy 2(5):787-796.
2. Anonymous (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
3. Baggio B, Budakovic A, Ferraro A, Checchetto S, Priante G, Musacchio E, Manzato E, Zaninotto M, Maresca MC (2005) Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. Transplantation 80:1349-1352.
4. Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in health pre- and postmenopausal women: two randomized controlled trials of Efacal® v. calcium alone. Br J Nutr 83:629-635.
5. Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15(4):377-386.
6. Cremers S, Garnero P (2006) Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease. Drugs 66(16):2031-2058.
7. Eriksen EF, Gundersen HJG, Melsen F, Mosekilde L (1984) Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res 5:243-252. (Pubitemid 14069658)
8. Gilman J, Cashman KD (2007) The effect of marine oil-derived n-3 fatty acids on transepithelial calcium transport in Caco-2 cell models of healthy and inflamed intestines. Br J Nutr 97:281-288.
9. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL (2007) An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6:2.
10. Ho″gstrom M, Nordstro″m P, Nordstro″m A (2007) n-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study. Am J Clin Nutr 85:803-807.
11. Kruger MC, Coetzer H, de Winter R et al (1998) Calcium, gammalinolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging Clin Exp Res 10 (5):385-394.
12. Larijani B, Moayyeri A, Keshtkar AA et al (2006) Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom 9(3):367-374.
13. Lucey AJ, Paschos GK, Cashman KD, Martínéz JA, Thorsdottir I, Kiely M (2008) Influence of moderate energy restriction and seafood consumption on bone turnover in overweight young adults. Am J Clin Nutr 87:1045-1052.
14. Macdonald HM, New SA, Golden MH et al (2004) Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79 (1):155-165.
15. Martínez-Ramírez MJ, Palma S, Martnez-González MA, Delgado-Martínez AD, de la Fuente C, Delgado-Rodríguez M (2007) Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Nutr 61 (9):1114-1120.
16. Salari P, Larijani B, Abdollahi M (2008a) Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 5(2):215-222. (Pubitemid 351513513)
17. Salari P, Rezaie A, Larijani B, Abdollahi M (2008b) A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 14(3):RA37-RA44.
18. Shen CL, Yeh JK, Rasty J et al (2006) Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 95:462-468.
19. Silverstrini G, Ballanti P, Patacchioli F et al (2005) Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of rat. J Mol Histol 36(1-2):59-67.
20. Sun L, Tamaki H, Ishimaru T et al (2004) Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and Perilla oil in the rat. Biosci Biotechnol Biochem 68:2613-2615.
21. Twiss JJ, Waltman NL, Berg K, Ott CD, Gross GJ, Lindsey AM (2009) An exercise intervention for breast cancer survivors with bone loss. J Nurs Scholarsh 41(1):20-27.
22. van Papendrop DH, Coetzer H, Kruger MC (1995) Biochemical profile of osteoporotic patients on essential faty acid supplementation. Nutr Res 15(3):325-334.
23. Watkins BA, Li Y, Seifert MF (2006) Dietary ration of n-6/n-3 PUFAs and DHA: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem 17 (4):282-289.
24. Weiss LA, Barrett-Connor E, von Mu″hlen D (2005) Ratio of n- 6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 81:934-938. (Pubitemid 41725005)
25. Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95(7):3597-3602.
26. Yousefzadeh G, Larijani B, Mohammadirad A, Heshmat R, Dehghan G, Rahimi R, Abdollahi M (2006) Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann N Y Acad Sci 1091:142-150.